Mouse CD40 Ligand/TNFSF5 Antibody Summary
Glu61-Leu260
Accession # P27548
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
![CD40 Ligand/TNFSF5 antibody in transfected CHO-S cells by Immunocytochemistry (ICC). CD40 Ligand/TNFSF5 antibody in transfected CHO-S cells by Immunocytochemistry (ICC).](https://resources.rndsystems.com/images/datasheets/CD40_Ligand_AF1163_Immunocytochemistry__Immunofluorescence_18377.jpg)
CD40 Ligand/TNFSF5 in Transfected CHO-S (positive) and wild type (negative) cells. CD40 Ligand/TNFSF5 was detected in immersion fixed transfected CHO-S (positive) and wild type (negative) cells using Goat Anti-Mouse CD40 Ligand/TNFSF5 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1163) at 5 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
![Proliferation Induced by CD40 Ligand/TNFSF5 and Neutralization by Mouse CD40 Ligand/TNFSF5 Antibody. Proliferation Induced by CD40 Ligand/TNFSF5 and Neutralization by Mouse CD40 Ligand/TNFSF5 Antibody.](https://resources.rndsystems.com/images/datasheets/antibody/CD40_Ligand_AF1163_Block_Neutralize_16499.jpg)
Proliferation Induced by CD40 Ligand/TNFSF5 and Neutralization by Mouse CD40 Ligand/TNFSF5 Antibody. Recombinant Mouse CD40 Ligand/TNFSF5 (Catalog # 8230-CL) induces proliferation in mouse splenic B cells in a dose-dependent manner (orange line), as measured by Resazurin (Catalog # AR002). Proliferation elicited by Recombinant Mouse CD40 Ligand/TNFSF5 (0.5 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Mouse CD40 Ligand/TNFSF5 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1163). The ND50 is typically 0.08-0.4 µg/mL.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CD40 Ligand/TNFSF5
CD40 ligand (CD40L), also known as CD154, TNFSF5, TRAP or gp39, is a 260 amino acid (aa) type II transmembrane glycoprotein belonging to the TNF family. Murine CD40L consists of a 22 aa cytoplasmic domain, a 24 aa transmembrane domain, and 214 aa extracellular domain bearing a single glycosylation site (1, 2). CD40L is expressed predominantly on activated CD4+ T lymphocytes, and also found in other types of cells, including NK cells, mast cells, basophils and eosinophils. Murine CD40L shares 78% amino acid sequence identity with human CD40L. Native bioactive soluble CD40L exists. Soluble human trimeric CD40L secreted by stimulated T cells has been shown to be generated by proteolysis in the microsomes (3). Both membrane bound and soluble CD40L induce similar effects on B cells (3, 4). The receptor of CD40L is CD40, a type I transmembrane glycoprotein belonging to the TNF receptor family. CD40 is expressed on B lymphocytes, monocytes, dendritic cells, and thymic epithelium. Although all monomeric, dimeric and trimeric forms of soluble CD40L can bind to CD40, the soluble trimeric form of CD40L has the most potent biological activity through oligomerization of cell surface CD40, a common feature of TNF receptor family members (2). The genetic defect in the hyper-IgM syndrome is due to point mutations or deletions of the gene encoding the CD40L, which prevent CD40L from interacting with CD40 (5-7). CD40L mediates a range of activities on B cells including induction of activation-associated surface antigen, entry into the cell cycle, isotype switching, Ig secretion, and memory generation (8, 9). CD40-CD40L interaction also plays important roles in monocyte activation and dendritic cell maturation (10).
- Armitage, R.J. et al. (1992) Nature 357:80.
- Hollenbaugh, D. et al. (1992) EMBO J. 11:4313.
- Fabienne, P. et al. (1996) J. Biol. Chem. 271:5965.
- Fabienne, P. et al. (1996) Eur. J. Immunol 26:725.
- Arrufo, A. et al. (1993) Cell 72:291.
- Hill, A. and N. Chapel et al. (1993) Nature 361:494.
- Korthauer, U. et al. (1993) Nature 361:539.
- Spriggs, M.K. et al. (1992) J. Exp. Med. 176:1543.
- Fanslow, W.C. et al. (1994) Seminars in Immunology 6:267.
- Kooten, C.V. and J. Banchereau (2000) J. Leukoc. Biol. 67:2.
Product Datasheets
Citations for Mouse CD40 Ligand/TNFSF5 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
7
Citations: Showing 1 - 7
Filter your results:
Filter by:
-
CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity
Authors: S de Silva, G Fromm, CW Shuptrine, K Johannes, A Patel, KJ Yoo, K Huang, TH Schreiber
Cancer Immunol Res, 2019-12-18;0(0):.
Species: Human
Sample Types: Protein
Applications: Western Blot -
Identification and characterisation of the CD40-ligand of Sigmodon hispidus
Authors: MS Russell, A Muralidhar, L Larocque, J Cao, Y Deschambau, J Varga, SN Thulasi Ra, X Li
PLoS ONE, 2018-07-27;13(7):e0199067.
Species: Mouse
Sample Types: Recombinant Protein
Applications: ELISA Development -
Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.
Authors: Gupta, Sachin, Termini, James M, Raffa, Francesc, Williams, Cindi-An, Kornbluth, Richard, Stone, Geoffrey
J Virol, 2013-11-13;88(3):1492-501.
Species: Mouse
Sample Types: Cell Culture Supernates
Applications: Western Blot -
The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance.
Authors: Akiyama T, Shimo Y, Yanai H, Qin J, Ohshima D, Maruyama Y, Asaumi Y, Kitazawa J, Takayanagi H, Penninger JM, Matsumoto M, Nitta T, Takahama Y, Inoue J
Immunity, 2008-09-19;29(3):423-37.
Species: Mouse
Sample Types: Whole Tissue
Applications: IHC-P, Neutralization -
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals.
Authors: Liu J, Yu Q, Stone GW, Yue FY, Ngai N, Jones RB, Kornbluth RS, Ostrowski MA
Vaccine, 2008-06-02;26(32):4062-72.
Species: Mouse
Sample Types: Recombinant Protein
Applications: Western Blot -
Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner.
Authors: Koguchi Y, Thauland TJ, Slifka MK, Parker DC
Blood, 2007-06-26;110(7):2520-7.
Species: Mouse
Sample Types: Whole Cells
Applications: ICC -
Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand.
Authors: Field AE, Wagage S, Conrad SM
Infect. Immun., 2007-04-02;75(6):3140-9.
Species: Human
Sample Types: Cell Culture Supernates
Applications: ELISA Development
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Mouse CD40 Ligand/TNFSF5 Antibody
There are currently no reviews for this product. Be the first to review Mouse CD40 Ligand/TNFSF5 Antibody and earn rewards!
Have you used Mouse CD40 Ligand/TNFSF5 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image